| Clinical challenges in diagnosis, tumor localization and treatment of tumor‐induced osteomalacia: outcome of a retrospective surveillance N Hidaka, M Koga, S Kimura, Y Hoshino, H Kato, Y Kinoshita, N Makita, ... Journal of Bone and Mineral Research 37 (8), 1479-1488, 2020 | 35 | 2020 |
| Incidence of complications in 25 adult patients with X-linked hypophosphatemia H Kato, M Koga, Y Kinoshita, Y Taniguchi, H Kobayashi, S Fukumoto, ... The Journal of Clinical Endocrinology & Metabolism 106 (9), e3682-e3692, 2021 | 24 | 2021 |
| Identification of ENPP1 haploinsufficiency in patients with diffuse idiopathic skeletal hyperostosis and early‐onset osteoporosis H Kato, AJ Ansh, ER Lester, Y Kinoshita, N Hidaka, Y Hoshino, M Koga, ... Journal of Bone and Mineral Research 37 (6), 1125-1135, 2020 | 22 | 2020 |
| Performance evaluation of the new chemiluminescent intact FGF23 assay relative to the existing assay system H Kato, N Hidaka, M Koga, N Ogawa, S Takahashi, H Miyazaki, ... Journal of Bone and Mineral Metabolism 40 (1), 101-108, 2022 | 15 | 2022 |
| Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption N Hidaka, H Kato, M Koga, M Katsura, Y Oyama, Y Kinoshita, S Fukumoto, ... Bone reports 15, 101144, 2021 | 15 | 2021 |
| Effect of conventional treatment on dental complications and ectopic ossifications among 30 adults with XLH H Kato, R Okawa, T Ogasawara, Y Hoshino, N Hidaka, M Koga, ... The Journal of Clinical Endocrinology & Metabolism 108 (6), 1405-1414, 2023 | 9 | 2023 |
| Genetics of diffuse idiopathic skeletal hyperostosis and ossification of the spinal ligaments H Kato, DT Braddock, N Ito Current Osteoporosis Reports 21 (5), 552-566, 2023 | 7 | 2023 |
| Utility of multimodality approach including systemic FGF23 venous sampling in localizing phosphaturic mesenchymal tumors H Kato, M Koga, Y Kinoshita, N Hidaka, Y Hoshino, Y Takashi, M Arai, ... Journal of the Endocrine Society 7 (2), bvac181, 2023 | 7 | 2023 |
| The pathophysiology of hypophosphatemia N Ito, N Hidaka, H Kato Best Practice & Research Clinical Endocrinology & Metabolism, 101851, 2023 | 5 | 2023 |
| Clinical performance of a new intact FGF23 immunoassay in healthy individuals and patients with chronic hypophosphatemia H Kato, H Miyazaki, T Kimura, Y Hoshino, N Hidaka, M Koga, M Nangaku, ... Bone Reports 18, 101659, 2023 | 5 | 2023 |
| Association of serum parathyroid hormone levels with all-cause and cause-specific mortality among US adults H Kato, N Ito, N Makita, M Nangaku, AM Leung, K Inoue Endocrine Practice 28 (1), 70-76, 2022 | 5 | 2022 |
| Massive calcification around large joints in a patient subsequently diagnosed with adult-onset hypophosphatasia M Koga, Y Kinoshita, H Kato, H Kobayashi, Y Shinoda, M Nangaku, ... Osteoporosis International, 1-5, 2022 | 4 | 2022 |
| The Effect of Asfotase Alfa on Plasma and Urine Pyrophosphate Levels and Pseudofractures in a Patient With Adult‐Onset Hypophosphatasia N Hidaka, H Murata, K Tachikawa, K Osaki, T Sekiyama, Y Kinoshita, ... Journal of Bone and Mineral Research Plus 7 (12), e10842, 2023 | 3 | 2023 |
| The effect of burosumab on intact and C‐terminal FGF23 measurements SL Ashrafzadeh‐Kian, N Ito, T Srivastava, U Garg, H Kato, ... Clinical endocrinology 99 (2), 152-157, 2023 | 3 | 2023 |
| Machine Learning–Based Prediction of Elevated PTH Levels Among the US General Population H Kato, Y Hoshino, N Hidaka, N Ito, N Makita, M Nangaku, K Inoue The Journal of Clinical Endocrinology & Metabolism 107 (12), 3222-3230, 2022 | 3 | 2022 |
| Radiological evaluation of pseudofracture after the administration of asfotase alfa in an adult with benign prenatal hypophosphatasia: a case report H Kato, N Hidaka, M Koga, Y Kinoshita, N Makita, M Nangaku, N Ito Bone Reports 16, 101163, 2022 | 3 | 2022 |
| Cartilage tissues regulate systemic aging via ectonucleotide pyrophosphatase/phosphodiesterase 1 in mice T Arima, K Sugimoto, T Taniwaki, K Maeda, Y Shibata, M Tateyama, ... Journal of Biological Chemistry 300 (1), 2024 | 2 | 2024 |
| Intact fibroblast growth factor 23 concentrations in hypophosphatemic disorders P Ramos, B Larson, S Ashrafzadeh-Kian, N Ito, H Kato, JA Bornhorst, ... Endocrine Practice 29 (3), 193-198, 2023 | 2 | 2023 |
| A Mild Case of Autosomal Recessive Osteopetrosis Masquerading as the Dominant Form Involving Homozygous Deep Intronic Variations in the CLCN7 Gene JG Hofstaetter, GJ Atkins, H Kato, M Kogawa, S Blouin, BM Misof, ... Calcified Tissue International 111 (4), 430-444, 2022 | 2 | 2022 |
| FGF-23, Left Ventricular Hypertrophy, and Mortality in Patients With CKD: A Revisit With Mediation Analysis N Hidaka, K Inoue, H Kato, Y Hoshino, M Koga, Y Kinoshita, Y Takashi, ... JACC: Advances 3 (1), 100747, 2024 | 1 | 2024 |
